The stock jumped 4.88 per cent to end at Rs 4,925 on BSE. Intra-day, it gained 5.41 per cent to Rs 4,950.
At NSE, shares of the company surged 5.25 per cent to close at Rs 4,939.55.
Standalone total income from operations also rose to Rs 729.43 crore during the quarter under review from Rs 648.98 crore a year ago.
Abbott India offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)